IDXX · Earnings call · 2026Q2T · Full report
Operating Expense Trends
IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 56 · Surprise 58 · In source text
Second-quarter operating expenses increased 10% year over year on a reported basis and 9% on a comparable basis. Management expects operating-expense growth to continue through the remainder of 2026 as IDEXX invests in its innovation agenda and global commercial capabilities. The company will expand field presence across four international countries and add targeted U.S. personnel during the second half. Incremental commercial and R&D investments are intended to support product launches, diagnostic utilization, and the long-term growth agenda.
Key facts
- IDEXX expects to maintain growth in operating expenses through the remainder of the year to advance investments in innovation and global commercial capabilities.
- Company expects to advance incremental investments in commercial and R&D during the second half to support long-term growth agenda.
- On a reported basis, operating expenses increased 10% year-over-year and 9% on a comparable basis in Q2.
- We will continue to make incremental investments in the second half to support longer-term growth.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | probable | — | IDEXX expects to maintain growth in operating expenses through the remainder of the year to advance investments in innovation and global… |